MoonLake Immunotherapeutics (MLTX) Enterprise Value (2020 - 2026)
MoonLake Immunotherapeutics' (MLTX) quarterly Enterprise Value came in at -$357.9 million in Q1 2026, up 24.66% year-on-year from -$287.1 million in Q1 2025, and up 9.15% quarter-over-quarter from -$394.0 million in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Enterprise Value (2020 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Enterprise Value history runs 7 years deep, the most recent figure standing at -$357.9 million for Q1 2026.
- On a quarterly basis, Enterprise Value rose 24.66% year-over-year to -$357.9 million in Q1 2026; TTM through Mar 2026 was -$357.9 million, a 24.66% increase from a year earlier, with the FY2025 full-year figure at -$394.0 million, up 10.76% from the prior year.
- Enterprise Value rose to -$357.9 million in Q1 2026 per MLTX's latest filing, from -$394.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at $31.0 million in Q2 2022 and bottomed at -$537.2 million in Q1 2024.
- The 5-year median for Enterprise Value is -$420.9 million (2025), against an average of -$331.9 million.
- Biggest YoY gain for Enterprise Value was 2928.04% in 2022; the steepest drop was 8533.99% in 2022.
- Year by year, Enterprise Value stood at -$52.2 million in 2022, then slumped by 843.98% to -$493.2 million in 2023, then gained by 10.49% to -$441.5 million in 2024, then advanced by 10.76% to -$394.0 million in 2025, then gained by 9.15% to -$357.9 million in 2026.
- Per Business Quant, the three latest MLTX Enterprise Value figures stand at -$357.9 million (Q1 2026), -$394.0 million (Q4 2025), and -$378.2 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | MoonLake Immunotherapeutics | 1.38 Bn | 1.02 Bn | - | -357.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -357.92 Mn |
| Dec 31, 2025 | -393.97 Mn |
| Sep 30, 2025 | -378.19 Mn |
| Jun 30, 2025 | -420.87 Mn |
| Mar 31, 2025 | -475.07 Mn |
| Dec 31, 2024 | -441.46 Mn |
| Sep 30, 2024 | -486.62 Mn |
| Jun 30, 2024 | -510.43 Mn |
| Mar 31, 2024 | -537.22 Mn |
| Dec 31, 2023 | -493.19 Mn |
| Sep 30, 2023 | -431.27 Mn |
| Jun 30, 2023 | -492.47 Mn |
| Mar 31, 2023 | -45.92 Mn |
| Dec 31, 2022 | -52.25 Mn |
| Sep 30, 2022 | -56.18 Mn |
| Jun 30, 2022 | 31.04 Mn |
| Mar 31, 2022 | -101.02 Mn |
| Dec 31, 2021 | -8.04 Mn |
| Sep 30, 2021 | -1.03 Mn |
| Jun 30, 2021 | -1.10 Mn |